Literature DB >> 10759693

Drug interactions avoided-a useful indicator of good prescribing practice.

D Williams1, A Kelly, J Feely.   

Abstract

AIMS: To develop an index of quality prescribing in general practice by investigating the incidence of potential drug interactions when medicines were coprescribed within the State supported General Medical Services (GMS) in Ireland.
METHODS: We determined an odds ratio (OR), as a measure of the relative risk of being exposed to a potential interaction, comparing the use of the H2-receptor antagonist, cimetidine, with that of the noninteracting agents ranitidine, famotidine and nizatidine in users and nonusers of warfarin, phenytoin and theophylline. RESULTS AND
CONCLUSIONS: In 86 510 prescriptions for the H2-receptor antagonists potentially interacting drugs were dispensed to 8188 (9%) patients in the Eastern Health Board Region of the GMS. We found that prescribers were significantly less likely to use cimetidine (OR = 0.20,95% CI 0. 17-0.21, P < 0.001) in those patients who were coprescribed warfarin, suggesting good prescribing practice within the GMS. Similarly there was preferential use of the noninteracting H2-receptor antagonists in patients receiving phenytoin or theophylline and the extent of this selective prescribing was in keeping with the rank order of severity of interaction with these drugs. This novel pharmacological index may be a sensitive marker of good prescribing practice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10759693      PMCID: PMC2014934          DOI: 10.1046/j.1365-2125.2000.00177.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  17 in total

Review 1.  Clinical relevance of cimetidine drug interactions.

Authors:  A F Shinn
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

2.  The influence of pharmacoeconomic factors on prescribing patterns in Ireland.

Authors:  J Feely
Journal:  Pharmacoeconomics       Date:  1992-08       Impact factor: 4.981

Review 3.  Performance indicators for primary care groups: an evidence based approach.

Authors:  A McColl; P Roderick; J Gabbay; H Smith; M Moore
Journal:  BMJ       Date:  1998-11-14

4.  Quality indicators for general practice: which ones can general practitioners and health authority managers agree are important and how useful are they?

Authors:  S M Campbell; M O Roland; J A Quayle; S A Buetow; P G Shekelle
Journal:  J Public Health Med       Date:  1998-12

Review 5.  Prevalence of potentially inappropriate long term prescribing in general practice in the United Kingdom, 1980-95: systematic literature review.

Authors:  S A Buetow; B Sibbald; J A Cantrill; S Halliwell
Journal:  BMJ       Date:  1996-11-30

6.  The influence of hospital-based prescribers on prescribing in general practice.

Authors:  J Feely; R Chan; J McManus; B O'Shea
Journal:  Pharmacoeconomics       Date:  1999-08       Impact factor: 4.981

7.  Performance indicators for general practice.

Authors:  F A Majeed; S Voss
Journal:  BMJ       Date:  1995-07-22

8.  Differential effects of cimetidine on theophylline metabolic pathways.

Authors:  J J Grygiel; J O Miners; R Drew; D J Birkett
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 9.  Drug interactions with antisecretory agents.

Authors:  P D Hansten
Journal:  Aliment Pharmacol Ther       Date:  1991       Impact factor: 8.171

10.  Utilization of appetite suppressants in England: a putative indicator of poor prescribing practice.

Authors:  S H Thomas; M Campbell
Journal:  Pharmacoepidemiol Drug Saf       Date:  1996-07       Impact factor: 2.890

View more
  3 in total

1.  Factor analysis improves the selection of prescribing indicators.

Authors:  Hanne Marie Skyggedal Rasmussen; Jens Søndergaard; Ineta Sokolowski; Jens Peter Kampmann; Morten Andersen
Journal:  Eur J Clin Pharmacol       Date:  2006-10-06       Impact factor: 2.953

2.  Gas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritis.

Authors:  M Yanagita; H Arai; K Ishii; T Nakano; K Ohashi; K Mizuno; B Varnum; A Fukatsu; T Doi; T Kita
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

3.  Adherence to guidelines for avoiding drug interactions associated with warfarin--a Nationwide Swedish Register Study.

Authors:  Jonatan D Lindh; Marine L Andersson; Buster Mannheimer
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.